Abstract
The study of Yeh et al. (1) raises awareness of the pulmonary dysfunction associated with type 2 diabetes. Prospective 2-year controlled lung function data regarding subjects with type 2 diabetes from the inhaled insulin (Exubera) development program have recently been published (2,3) and extend the results reported by Yeh et al. The subjects enrolled in these studies were predominantly middle-aged, type 2 diabetic Caucasian men and women who had never smoked or who had stopped smoking and who had normal or near-normal lung function at study entry. Barnett et al. (2) observed mean annualized declines in forced expiratory volume in 1 s (FEV1) and carbon …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
